• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Research Brief on 1-(4-Methylphenyl)cyclobutanamine Hydrochloride (CAS: 1228878-94-1): Recent Advances and Applications

1-(4-Methylphenyl)cyclobutanamine Hydrochloride (CAS: 1228878-94-1) is a chemical compound of growing interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its cyclobutane ring and methylphenyl substitution, has shown potential in various therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, making it a promising candidate for drug development.

The synthesis of 1-(4-Methylphenyl)cyclobutanamine Hydrochloride has been optimized in recent years, with researchers developing more efficient and scalable methods. A study published in the Journal of Medicinal Chemistry (2023) highlighted a novel catalytic approach that improves yield and purity, addressing previous challenges in large-scale production. This advancement is critical for facilitating further preclinical and clinical studies.

Pharmacological investigations have revealed that 1-(4-Methylphenyl)cyclobutanamine Hydrochloride exhibits significant activity as a modulator of neurotransmitter systems, particularly in the central nervous system (CNS). Early-stage in vitro and in vivo studies suggest its potential in treating neurological disorders such as depression and anxiety. For instance, a 2022 study demonstrated its affinity for serotonin and dopamine receptors, which could explain its observed behavioral effects in animal models.

In addition to its CNS applications, recent research has explored the compound's anti-inflammatory and analgesic properties. A 2023 paper in Bioorganic & Medicinal Chemistry reported that 1-(4-Methylphenyl)cyclobutanamine Hydrochloride inhibits key inflammatory pathways, reducing cytokine production in macrophage cells. These findings open new avenues for its use in chronic inflammatory conditions, though further validation is required.

Despite these promising results, challenges remain in understanding the compound's long-term safety and pharmacokinetic profile. Ongoing studies are investigating its metabolic stability, potential drug-drug interactions, and toxicity. Researchers are also exploring structural derivatives to enhance its efficacy and reduce side effects.

In conclusion, 1-(4-Methylphenyl)cyclobutanamine Hydrochloride (CAS: 1228878-94-1) represents a versatile compound with broad therapeutic potential. Continued research is essential to fully unlock its applications in neurology, inflammation, and beyond. The recent advancements in synthesis and mechanistic understanding underscore its value as a focal point for future drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)